Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DU4S5D
|
|||
| Drug Name |
Posoleucel
|
|||
| Synonyms |
ALVR105
Click to Show/Hide
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Hemorrhagic cystitis [ICD-11: GC00.1] | Phase 3 | [1] | |
| Company |
AlloVir Waltham, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04390113) Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant (HCT). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.